113 related articles for article (PubMed ID: 2432792)
1. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
Job LP; Lyden DC; Huber SA
Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.
Huber SA; Lodge PA
Am J Pathol; 1984 Jul; 116(1):21-9. PubMed ID: 6331168
[TBL] [Abstract][Full Text] [Related]
5. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
Guthrie M; Lodge PA; Huber SA
Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
[TBL] [Abstract][Full Text] [Related]
6. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
7. [Experimental comparison of two coxsackievirus B3 variants in murine myocardial cells].
Cui X; Gomez R; Sun G; Ma L; Xu Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):274-6. PubMed ID: 15617347
[TBL] [Abstract][Full Text] [Related]
8. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
10. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
11. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.
Gauntt CJ; Trousdale MD; LaBadie DR; Paque RE; Nealon T
J Med Virol; 1979; 3(3):207-20. PubMed ID: 225441
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.
Estrin M; Huber SA
Am J Pathol; 1987 May; 127(2):335-41. PubMed ID: 3034068
[TBL] [Abstract][Full Text] [Related]
13. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
14. Murine natural killer cells limit coxsackievirus B3 replication.
Godeny EK; Gauntt CJ
J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
[TBL] [Abstract][Full Text] [Related]
15. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
Loudon RP; Moraska AF; Huber SA; Schwimmbeck P; Schultheiss P
J Virol; 1991 Nov; 65(11):5813-9. PubMed ID: 1656071
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.
Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ
J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222
[TBL] [Abstract][Full Text] [Related]
18. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
Lodge PA; Herzum M; Olszewski J; Huber SA
Am J Pathol; 1987 Sep; 128(3):455-63. PubMed ID: 2957924
[TBL] [Abstract][Full Text] [Related]
20. Levamisole exacerbates coxsackievirus B3-induced murine myocarditis.
Gudvangen RJ; Duffey PS; Paque RE; Gauntt CJ
Infect Immun; 1983 Sep; 41(3):1157-65. PubMed ID: 6309663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
